Analysts Set Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Price Target at $63.67
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been given an average recommendation of “Buy” by the seven analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been given an average recommendation of “Buy” by the seven analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to […]
